Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy or Pelvic Lymphadenectomy: A Prospective Observational Study
M.D. Anderson Cancer Center
Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Description
Primary Objectives: The objective of this study is to evaluate the protective benefit to performing LVB surgery at the time of ILND and/or PLND. In the secondary objective, we will compare the medical outcomes for patients that received the LVB surgery with those receiving standard surgery in whom the intervention could not be performed.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Eligibility Criteria: 1. Patients greater than or equal to 18 years of age. 2. Patients willing to participate. 3. Patients able to complete informed consent. 4. Patients undergoing ILND and/or PLND. Exclusion Criteria: 1. Patients taking anticoagulants within 7 days prior to surgery. 2. Patients that are known to be pregnant at the time of surgery. 3. Patients are available for follow-up less than 18 months or do not undergo measurements within the scheduled period. 4. Patients with BMI greater than 50.0.
Interventions
- ProcedureLymphovenous bypass procedure
Participants will return to the clinic 14 days, 6 months, 12 months, 18 months, and 24 months after your surgery for measurements of your legs to see if there are changes over time
Location
- MD Anderson Cancer CenterHouston, Texas